source
- Blood centers can help biopharma scale cell and gene therapiesBlood centers have the donors, resources and community footprint drug sponsors need to solve supply chain issues around cell and gene therapies.BioSpace · 1h ago↗ source
- AstraZeneca’s Etcamah fails Phase 3 trial, dashing hopes for $2.9 billion breast cancer marketAstraZeneca’s oral selective estrogen receptor degrader Etcamah was evaluated in the Phase 3 SERENA-4 trial as a first-line option for patients with ER-positive, HER2-negative advanced breast cance…